Table 1 Differentially expressed common genes after shikonin treatment by MCF-7, SK-BR-3, and MDA-MB-231 cells. (log2 ratio).

From: RNA-seq transcriptome analysis of breast cancer cell lines under shikonin treatment

Genes

Entrez ID

MCF-7

SK-BR-3

MDA-MB-231

RMRP

6023

Infinity

Infinity

Infinity

HSPA6

3310

8.48

Infinity

8.41

HMOX1

3162

6.18

5.60

2.31

PGF

5228

5.32

3.83

1.01

HSPA1A

3303

3.92

6.11

4.69

HSPA1B

3304

3.75

6.12

4.04

ATF3

467

3.69

2.03

4.08

DNAJB1

3337

3.37

4.70

3.51

OSGIN1

29948

3.19

2.79

1.36

TNFSF9

8744

3.03

2.28

3.91

PPP1R15A

23645

2.84

2.89

2.06

ARC

23237

2.70

2.84

Infinity

MIR22,MIR22HG

407004

2.64

4.00

2.09

SNAI1

6615

2.64

2.06

4.52

RN7SK

125050

2.54

1.01

Infinity

UBC

7316

2.53

2.40

1.02

IER5

51278

2.42

1.21

1.99

MAFF

23764

2.19

2.28

1.33

ZFAND2A

90637

2.12

4.07

2.99

SESN2

83667

2.00

1.28

1.22

CDKN1A

1026

1.91

3.56

2.19

HSPH1

10808

1.91

2.73

1.25

BAG3

9531

1.89

3.68

1.33

IDI2-AS1

55853

1.70

1.54

Infinity

SIK1

150094

1.61

1.00

1.30

DUSP2

1844

1.60

3.01

5.32

DUSP1

1843

1.55

2.88

1.20

GADD45G

10912

1.53

2.42

3.17

PIM1

5292

1.43

2.00

1.09

MAP1LC3B

81631

1.39

1.75

1.17

SLC25A25

114789

1.34

1.51

1.26

OSER1

51526

1.34

1.80

1.61

TSPYL2

64061

1.32

1.41

1.41

RND3

390

1.30

2.34

1.06

MAP1LC3B2

643246

1.24

1.31

1.34

CSRNP1

64651

1.06

2.25

1.79

RN7SL1

6029

−1.22

1.15

1.32

ETAA1

54465

−1.45

−1.15

−1.68